JPH0158167B2 - - Google Patents
Info
- Publication number
- JPH0158167B2 JPH0158167B2 JP57051165A JP5116582A JPH0158167B2 JP H0158167 B2 JPH0158167 B2 JP H0158167B2 JP 57051165 A JP57051165 A JP 57051165A JP 5116582 A JP5116582 A JP 5116582A JP H0158167 B2 JPH0158167 B2 JP H0158167B2
- Authority
- JP
- Japan
- Prior art keywords
- present
- substance
- amphotericin
- hours
- observed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 claims description 8
- 241000251730 Chondrichthyes Species 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 5
- 230000000843 anti-fungal effect Effects 0.000 claims description 5
- 229910052740 iodine Inorganic materials 0.000 claims description 5
- 239000011630 iodine Substances 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 3
- 229940040511 liver extract Drugs 0.000 claims description 3
- 239000000126 substance Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 9
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 7
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 7
- 229960003942 amphotericin b Drugs 0.000 description 7
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 206010007134 Candida infections Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 201000003984 candidiasis Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000001388 Opportunistic Infections Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000022534 cell killing Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 208000035943 Aphagia Diseases 0.000 description 1
- 241001552704 Centrophorus Species 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000755266 Kathetostoma giganteum Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57051165A JPS58170718A (ja) | 1982-03-31 | 1982-03-31 | 抗眞菌作用を有する薬剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57051165A JPS58170718A (ja) | 1982-03-31 | 1982-03-31 | 抗眞菌作用を有する薬剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58170718A JPS58170718A (ja) | 1983-10-07 |
| JPH0158167B2 true JPH0158167B2 (https=) | 1989-12-11 |
Family
ID=12879205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57051165A Granted JPS58170718A (ja) | 1982-03-31 | 1982-03-31 | 抗眞菌作用を有する薬剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58170718A (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA876171B (en) * | 1986-08-21 | 1988-10-26 | Broadbent James Meredyth | Active principle isolated from shark tissue |
| US6110472A (en) * | 1992-12-10 | 2000-08-29 | Hemogen Inc. | Vitamin B12 containing scalp and skin treatment compositions |
-
1982
- 1982-03-31 JP JP57051165A patent/JPS58170718A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58170718A (ja) | 1983-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5571520A (en) | Molecular crystal redox device for pharmaceuticals | |
| JPH03504121A (ja) | 抗ウイルス及び抗菌組成物並びに使用方法 | |
| US7199159B2 (en) | Use of biguanide derivatives for making a medicine having a wound healing effect | |
| JP7297021B2 (ja) | 乳酸菌発酵産物含有外傷外用組成物 | |
| Arika et al. | Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs | |
| JP3019996B2 (ja) | 白癬治療剤 | |
| JPH0228319B2 (https=) | ||
| EP2528595A1 (de) | Verbindungen zur verwendung bei der behandlung von erkrankungen | |
| US5102902A (en) | Reagents and method for therapeutic treatment of multiple sclerosis | |
| JPH0158167B2 (https=) | ||
| US20040138174A1 (en) | Use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for treating cervical erosion | |
| CN102363040A (zh) | 用于粘膜组织的抗微生物肽制剂 | |
| US4929619A (en) | Anti-infective methods and compositions | |
| NL8105635A (nl) | Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking. | |
| KR100682979B1 (ko) | 항균 감염증 및 항염증 작용에 대한 예방 치료용 조성물 및이를 이용하여 얻어진 무좀치료제 | |
| CN111228462B (zh) | 一种抗微生物肽制剂及其制备方法 | |
| RU2725622C1 (ru) | Фармацевтическая композиция для лечения и/или профилактики заболеваний печени | |
| CN117018053A (zh) | 一种足部抗菌喷雾剂及其制备方法和应用 | |
| US7704976B2 (en) | Use of N-acetyl-D-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention | |
| WO2021184115A1 (en) | Use of bucillamine in the treatment of infectious diseases | |
| CN104174009A (zh) | 一种蝇蛆蛋白制剂及用途 | |
| US3773959A (en) | Fungicidal compositions comprising griseofulvin and thiabendazole and methods of utilizing same | |
| RU2781050C1 (ru) | Бактерицидная фармацевтическая композиция для местного применения в форме геля бактерицидного с эндолизином | |
| CN1289144C (zh) | 治疗放射性黏膜损伤、复发性口疮、牙周炎的药物 | |
| RU2797957C1 (ru) | Антисептическая комбинация, антисептическая фармацевтическая композиция и их применение |